Home
Morphic Therapeutic, Inc.

Morphic Therapeutic, Inc. Market Share Analysis for May 2026

Health > Biotechnology and Pharmaceuticals

Domainmorphictx.com

Year Founded2015

Employees51 - 200

Annual Revenue$15M - $25M

Morphic Therapeutic, Inc.

Morphic Therapeutic, Inc. (including company regionals)

morphictx.com

See more website traffic and engagement information

Morphic Therapeutic, Inc. Revenue up to May 2026 is 15M - 25M

revenue generated by Morphic Therapeutic, Inc. top domains

Morphic Therapeutic, Inc. top domains revenue over 3 years

Revenue for Morphic Therapeutic, Inc. top domains

morphictx.com15M - 25M

See more with Sales Intelligence

Total visits to Morphic Therapeutic, Inc.'s top domains

Understand Morphic Therapeutic, Inc. market share and potential market reach.

Total visits last 3 months

No Data to Display

Avg. visit duration in Morphic Therapeutic, Inc.'s top domains

Analyze Morphic Therapeutic, Inc. engagement metrics.

Average visit duration last 3 months

No Data to Display

Avg. pageviews on Morphic Therapeutic, Inc.'s top domains

See how Morphic Therapeutic, Inc. keep users engaged, nurture their interest, and encourage them to take the next step.

Average page views last 3 months

No Data to Display

Morphic Therapeutic, Inc. top competitors by domain

Looks like there’s not enough data here

No Data to Display

Top technologies used by Morphic Therapeutic, Inc.

These are the website technologies, by industry, used by Morphic Therapeutic, Inc. top domains

Widget (4)

Twemoji

Content Management System (3)

WordPress

Marketing (2)

Google Marketing Platform

Mobile (2)

Meta Viewport

More Technologies

10

See all

News & Signals from Morphic Therapeutic, Inc.

With Similarweb Sales signals alerts, you’ll receive daily updates of recognized buying signals whenever new opportunities or threats arise in your target audience.

NewsMorphictx is developing preclinical pipeline of other molecules for the treatment of autoimmune diseases, pulmonary hypertensive diseases, fibrotic diseases and cancer.Additionally, Morphic is developing a preclinical pipeline of other molecules for the treatment of autoimmune diseases, pulmonary hypertensive diseases, fibrotic diseases and cancer.

NewsMorphictx is developing integrins.Morphic is working on a class of proteins called integrins, which traffic T cells.

NewsMorphictx is developing treatment for inflammatory bowel disease on Jul 15th '24.Morphic is developing a treatment for inflammatory bowel disease.